EFTR - Effector Therapeutics - Stock Forecast

Coverage Performance Price Targets & Ratings Chart Insider Trading

EFTR is currently covered by 4 analysts with an average price target of $11.87. This is a potential upside of $9.88 (496.48%) from yesterday's end of day stock price of $1.99.

Effector Therapeutics's activity chart (see below) currently has 12 price targets and 20 ratings on display. The stock rating distribution of EFTR is 11.11% HOLD and 88.89% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 35% with an average time for these price targets to be met of 235.6 days.

Highest price target for EFTR is $1.3, Lowest price target is $1.3, average price target is $11.87.

Most recent stock forecast was given by BENJAMIN BURNETT from STIFEL on 26-May-2023. First documented stock forecast 13-Sep-2021.

Best performing analysts who are covering EFTR - Effector Therapeutics:

Judah Frommer Reni Benjamin Benjamin Burnett Mara Goldstein Louise Chen

Currently out of the existing stock ratings of EFTR, 1 are a HOLD (11.11%), 8 are a BUY (88.89%).

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

1.3

$-0.83 (-38.97%)

10 months 24 days ago

1/3 (33.33%)

$0.64 (96.97%)

11

Buy

11 months 9 days ago

2/3 (66.67%)

$9.66 (222.58%)

740

Buy

1

$-1.13 (-53.05%)

2

1 years 3 months 10 days ago

3/4 (75%)

$0.6 (150.00%)

427

Buy

1 years 10 months 13 days ago

0/2 (0%)

$30.7 (159.07%)

Buy

2 years 15 days ago

0/1 (0%)

$7.79 (63.80%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is EFTR (Effector Therapeutics) average time for price targets to be met?

On average it took 235.6 days on average for the stock forecasts to be realized with a an average price target met ratio 35

Which analyst has the current highest performing score on EFTR (Effector Therapeutics) with a proven track record?

JUDAH FROMMER

Which analyst has the current lower performing score on EFTR (Effector Therapeutics) with a proven track record?

LOUISE CHEN

Which analyst has the most public recommendations on EFTR (Effector Therapeutics)?

Judah Frommer works at CREDIT SUISSE and has 7 price targets and 5 ratings on EFTR

Which analyst is the currently most bullish on EFTR (Effector Therapeutics)?

Louise Chen with highest potential upside - $0

Which analyst is the currently most reserved on EFTR (Effector Therapeutics)?

Reni Benjamin with lowest potential downside - -$1.13

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?